Associated factors and comorbidities in patients with pyoderma gangrenosum in Germany: A retrospective multicentric analysis in 259 patients

Orphanet Journal of Rare Diseases

Volumn 8, Issue 1, 2013, Pages

  Al Ghazal, Philipp ^a   Herberger, Katharina ^b   Schaller, Jörg ^c   Strölin, Anke ^d   Hoff, Norman Philipp ^e   Goerge, Tobias ^f   Roth, Hannelore ^g   Rabe, Eberhard ^h   Karrer, Sigrid ⁱ   Renner, Regina ^j   Maschke, Jan ^k   Horn, Thomas ^l   Hepp, Julia ^m   Eming, Sabine ⁿ   Wollina, Uwe ^o   Zutt, Markus ^p   Sick, Isabell ^q   Splieth, Benno ^r   Dill, Dorothea ^s   Klode, Joachim ^t   Dissemond, Joachim ^t   more..

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF HAMBURG   (Germany)

^c St Barbara Clinics   (Germany)

^d UNIVERSITY OF TÜBINGEN   (Germany)

^e HEINRICH HEINE UNIVERSITY   (Germany)

^f UNIVERSITY OF MÜNSTER   (Germany)

^g Praxis für Venen und Hauterkrankungen   (Germany)

^h UNIVERSITY OF BONN   (Germany)

ⁱ UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^j UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^k General Hospital of Goerlitz   (Germany)

^l HELIOS KLINIKUM KREFELD   (Germany)

^m UNIVERSITY HOSPITAL ULM   (Germany)

ⁿ UNIVERSITY OF COLOGNE   (Germany)

^o DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^p Hospital Bremen Mitte   (Germany)

^q LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^r Vital Klinik   (Germany)

^s Dept Diagn/Interventional Radiol   (Germany)

^t UNIVERSITY OF ESSEN MEDICAL SCHOOL   (Germany)

more..

Author keywords

Chronic ulcer; Comorbidities; Diabetes mellitus; Metabolic syndrome; Pyoderma gangrenosum

Indexed keywords

CREATININE;

ADULT; AGED; ANEMIA; ARTICLE; CHRONIC ACTIVE HEPATITIS; CLINICAL STUDY; COMORBIDITY; CROHN DISEASE; DIABETES MELLITUS; DIABETIC PATIENT; DISEASE ASSOCIATION; DIVERTICULOSIS; DUODENUM ULCER; ENDOCRINE DISEASE; ENTERITIS; FEMALE; GERMANY; HEALTH CARE FACILITY; HUMAN; INTESTINE POLYP; KIDNEY DISEASE; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MULTICENTER STUDY; NEOPLASM; POPULATION; PYODERMA GANGRENOSUM; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; STOMACH ULCER; THYROID DISEASE; ULCERATIVE COLITIS; WOUND CARE;

ADULT; AGED; AGED, 80 AND OVER; ENDOCRINE SYSTEM DISEASES; FEMALE; GERMANY; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; NEOPLASMS; PYODERMA GANGRENOSUM; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84883526906     PISSN: None     EISSN: 17501172     Source Type: Journal    
DOI: 10.1186/1750-1172-8-136     Document Type: Article

References (31)

1. Pyoderma gangrenosum: a report of 44 cases with follow up. von den Driesch P, Br J Dermatol 1997 137 6 1000 1005 10.1111/j.1365-2133.1997.tb01568.x 9470924 (Pubitemid 28011148)
2. Pyoderma gangrenosum: a review of 86 patients. Powell F, Schroeter A, Su W, Perry H, Q J Med 1985 55 173 186 3889978 (Pubitemid 15047362)
3. Pyoderma gangrenosum. A comparison of typical and atypical forms with an emphasis on time to remission. Case review of 86 patients from 2 institutions. Bennett M, Jackson J, Jorizzo J, Fleischer A, White W, Callen J, Medicine (Baltimore) 2000 79 1 37 46 10.1097/00005792-200001000-00004 (Pubitemid 30077735)
4. Autoinflammatory skin disorders in inflammatory bowel diseases, pyoderma gangrenosum and sweet's syndrome: a comprehensive review and disease classification criteria. Marzano AV, Ishak RS, Saibeni S, Crosti C, Meroni PL, Cugno M, Clin Rev Allergy Immunol in press
5. Role of inflammatory cells, cytokines and matrix metalloproteinases in neutrophil-mediated skin diseases. Marzano AV, Cugno M, Trevisan V, Fanoni D, Venegoni L, Berti E, Crosti C, Clin Exp Immunol 2010 162 1 100 107 10.1111/j.1365-2249.2010.04201.x 20636397
6. Incidence, mortality, and disease associations of pyoderma gangrenosum in the United Kingdom: a retrospective cohort study. Langan SM, Groves RW, Card TR, Gulliford MC, J Invest Dermatol 2012 132 9 2166 2170 10.1038/jid.2012.130 22534879
7. T-cell receptor repertoire in pyoderma gangrenosum: evidence for clonal expansions and trafficking. Brooklyn TN, Williams AM, Dunnill MG, Probert CS, Br J Dermatol 2007 157 5 960 966 10.1111/j.1365-2133.2007.08211.x 17935516 (Pubitemid 47583536)
8. Aberrant neutrophil trafficking and metabolic oscillations in severe pyoderma gangrenosum. Adachi Y, Kindzelskii AL, Cookingham G, Shaya S, Moore EC, Todd RF, Petty HR, J Invest Dermatol 1998 111 2 259 268 10.1046/j.1523-1747. 1998.00311.x 9699727 (Pubitemid 28354713)
9. Reduction of interleukin-6, interleukin-8, and anti-phosphatidylserine- prothrombin complex antibody by granulocyte and monocyte adsorption apheresis in a patient with pyoderma gangrenosum and ulcerative colitis. Kawakami T, Yamazaki M, Soma Y, Am J Gastroenterol 2009 104 9 2363 2364 10.1038/ajg.2009.271 19727102
10. Pyoderma gangrenosum-a review. Wollina U, Orphanet J Rare Dis 2007 2 19 10.1186/1750-1172-2-19 17433111
11. Impaired podosome formation and invasive migration of macrophages from patients with a PSTPIP1 mutation and PAPA syndrome. Cortesio CL, Wernimont SA, Kastner DL, Cooper KM, Huttenlocher A, Arthritis Rheum 2010 62 2556 2558 10.1002/art.27521 20506269
12. Clinical, molecular, and genetic characteristics of PAPA syndrome: a review. Smith EJ, Allantaz F, Bennett L, Zhang D, Gao X, Wood G, Kastner DL, Punaro M, Aksentijevich I, Pascual V, Wise CA, Curr Genomics 2010 11 7 519 527 10.2174/138920210793175921 21532836
13. Targeted treatment of pyoderma gangrenosum in PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome with the recombinant human interleukin-1 receptor antagonist anakinra. Brenner M, Ruzicka T, Plewig G, Thomas P, Herzer P, Br J Dermatol 2009 161 5 1199 1201 10.1111/j.1365-2133.2009.09404.x 19673875
14. Brief report: genotype, phenotype, and clinical course in five patients with PAPA syndrome (pyogenic sterile arthritis, pyoderma gangrenosum, and acne). Demidowich AP, Freeman AF, Kuhns DB, Aksentijevich I, Gallin JI, Turner ML, Kastner DL, Holland SM, Arthritis Rheum 2012 64 6 2022 2027 10.1002/art.34332 22161697
15. Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH)-a new autoinflammatory syndrome distinct from PAPA syndrome. Braun-Falco M, Kovnerystyy O, Lohse P, Ruzicka T, J Am Acad Dermatol 2012 66 3 409 415 10.1016/j.jaad.2010.12.025 21745697
16. Pyoderma gangrenosum, acne and suppurative hidradenitis syndrome following bowel bypass surgery. Marzano AV, Ishak RS, Colombo A, Caroli F, Crosti C, Dermatology 2012 225 3 215 219 10.1159/000343602 23171584
17. Pyogenic arthritis, pyoderma gangrenosum, acne, and hidradenitis suppurativa (PAPASH): a new autoinflammatory syndrome associated with a novel mutation of the PSTPIP1 gene. Marzano AV, Trevisan V, Gattorno M, Ceccherini I, De Simone C, Crosti C, JAMA Dermatol 2013 149 6 762 764 10.1001/jamadermatol. 2013.2907 23571383
18. Pyoderma gangrenosum: a retrospective review of patient characteristics, comorbidities, and therapy in 103 patients. Binus AM, Qureshi AA, Li VW, Winterfield LS, Br J Dermatol 2011 165 6 1244 1250 10.1111/j.1365-2133.2011. 10565.x 21824126
19. Investigation of new-cofactors in 49 patients with pyoderma gangrenosum. Al Ghazal P, Körber A, Klode J, Dissemond J, J Dtsch Dermatol Ges 2012 10 4 251 257 21762379
20. Pyoderma gangrenosum. Callen J, Lancet 1998 351 581 585 10.1016/S0140-6736(97)10187-8 9492798 (Pubitemid 28077573)
21. Pyoderma gangrenosum: classification and management. Powell F, Su W, Perry H, J Am Acad Dermatol 1996 34 395 409 10.1016/S0190-9622(96)90428-4 8609250 (Pubitemid 26083814)
22. Pyoderma gangrenosum: clinicopathologic correlation and proposed diagnostic criteria. Su WP, Davis MD, Weenig RH, Powell FC, Perry HO, Int J Dermatol 2004 43 11 790 800 10.1111/j.1365-4632.2004.02128.x 15533059 (Pubitemid 39529936)
23. Clinical features of pyoderma gangrenosum and current diagnostic trends. Hadi A, Lebwohl M, J Am Acad Dermatol 2011 64 5 950 954 10.1016/j.jaad.2010.01. 049 21292348
24. Pyoderma gangrenosum. Wolff K, Stingl G, Fitzpatrick's Dermatology in general medicine New York: Mc Graw-Hill, Freedberg IM, Eisen AZ, Wolff K, 5 1999 2207 2213 24006182
25. "TRECID", TNFalpha related chronic inflammatory diseases-a new multiple diseases bridging concept. Müller-Ladner U, Alten R, Heiligenhaus A, Kekow J, Koletzko S, Mrowietz U, Ochsenkühn T, Radke M, Reich K, Rudwaleit M, Schreiber S, Dtsch Med Wochenschr 2009 134 42 2132 2136 10.1055/s-0029-1242011 19809965
26. Pyoderma gangrenosum: associations revisited. Ko CB, Walton S, Wyatt EH, Int J Dermatol 1992 31 574 577 10.1111/j.1365-4362.1992.tb02723.x 1428451
27. The evolution of pyoderma gangrenosum: a clinicopathologic correlation. Hurwitz RM, Haseman JH, Am J Dermatopathol 1993 15 28 33 10.1097/00000372- 199302000-00005 8434729 (Pubitemid 23057420)
28. Pyoderma gangrenosum: study of 21 patients and proposal of a 'clinicotherapeutic' classification. Marzano AV, Trevisan V, Lazzari R, Crosti C, J Dermatolog Treat 2011 22 5 254 260 10.3109/09546631003686069 20666672
29. Pyoderma gangrenosum. Bolognia J, Jorizzo J, Rapini R, Dermatology 2003 1 415 418
30. Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions. Davidovici B, Sattar N, Prinz J, Puig L, Emery P, Barker JN, van de Kerkhof P, Stahle M, Nestle FO, Girolomonis G, Krieger JG, J Invest Dermatol 2010 130 7 1785 1796 10.1038/jid.2010.103 20445552
31. Leptin and the skin: a new frontier. Poeggeler B, Schulz C, Pappolla M, Exp Dermatol 2010 19 1 12 18 10.1111/j.1600-0625.2009.00930.x 19601981